Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost Implant System in glaucoma and ocular hypertension
NCT07218796Phase 3Recruiting
- Start
- Oct 2025
- Primary completion
- May 2029
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of Bimatoprost Implant System in open-angle glaucoma (OAG), ocular hypertension. Started Oct 2025; status: recruiting.
02
Drugs
Bimatoprost Implant System
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT07218796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218796.